title: Intensive glycemic control and cardiovascular disease observations from the ACCORD study: now what can a clinician possibly think?
authors.forename: William T
authors.initials: WT
authors.lastname: Cefalu
authors.forename: Karol
authors.initials: K
authors.lastname: Watson
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D003925:Diabetic Angiopathies / Q000097:blood* / Q000453:epidemiology; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012016:Reference Values; D015203:Reproducibility of Results
chemical_list: D001786:Blood Glucose; D008078:Cholesterol, LDL; D006442:Glycated Hemoglobin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors